首页>
外国专利>
COMBINATION OF ADRENERGIC AGONIST AND NMDA ANTAGONIST FOR RELIEVING CHRONIC PAIN WITHOUT ADVERSE SIDE EFFECTS
COMBINATION OF ADRENERGIC AGONIST AND NMDA ANTAGONIST FOR RELIEVING CHRONIC PAIN WITHOUT ADVERSE SIDE EFFECTS
展开▼
机译:肾上腺皮质激素激动剂和NMDA拮抗剂的组合,可缓解慢性疼痛而无不良影响
展开▼
页面导航
摘要
著录项
相似文献
摘要
A combination of two drugs, from different and unrelated categories, provides effective and long-lasting relief from neuropathic pain and other chronic or intractable pain. Both drugs can be taken in a painless non-invasive manner, such as by means of pills or skin patches. One drug is an 2 adrenergic agonist, exemplified by clonidine. These agents reduce blood pressure and have sedative-hypnotic effects; those are unwanted side effects in a chronic daily treatment for pain. The other drug is an NMDA antagonist which can be described as mild, minimally toxic, and/or inherently safe (or safened). Three such classes of drugs have been shown to work exceptionally well, with clonidine, in reducing neuropathic pain for prolonged periods: (1) aryl-cyclo-alkanolamine drugs such as procyclidine and biperiden; (2) tricyclo-alkylamine drugs such as ethopropazine; and (3) adamantane derivatives such as memantine. None of these drugs, by itself, can provide effective relief for neuropathic pain; at doses required to provide short-term relief, they cause adverse side effects, and any pain relief they provide is relatively brief. However, when combined with an 2 adrenergic agonist, the two drugs potentiate one another's pain-relieving action, and provide potent and sustained relief, even when each drug is administered at a low dosage that is below its threshold for causing adverse side effects.
展开▼